Physicians Need Better Guidelines for Disclosing Conflicts of Interest Via Social Media
It is well-known that space constraints inherent in search ads and social media applications such as Twitter prevent the pharmaceutical industry from disclosing FDA-required important safety information (ISI) in ads/messages that...
Public Citizen Tracks “Bad Pharma” Financial Settlements
Public Citizen, the citizen "watch dog" group, has documented all major financial settlements and court judgments between pharmaceutical manufacturers and the federal and state governments since 1991. Its latest report (here)...
Happy Anniversary! First Ever Pharmaguy Social Media Procrastinator Award Goes to…
Today is the third anniversary of the first day of the 2-day November 2009, FDA public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and...
Mobile Apps vs. Mobile Optimization: Which Offers Pharma the Best ROI?
According to the "Mobile Health 2012" survey on the use of cellphones for healthcare that was just been released by the Pew Internet and American Life Project, "half of smartphone owners...
Will FDASIA Get FDA Off Its Butt to Finally Issue Social Media Guidance?
I noted with interest the headline in today's FDA News email: "OPDP: Social Media Guidance Will Be High Priority in 2013"." Here's the teaser copy that explains what's going one:
"The Office...
Sanofi Accepts Pharmaguy’s Social Media Pioneer Award
A few weeks ago -- before hurricane Sandy disrupted life as we know here on the east coast -- I presented the coveted bright yellow Hawaiian shirt/Pharmaguy Social Media Pioneer Award...
Pharma Testimonial Videos Overstate Efficacy More Often Than Other Ads
Mark Senak over at Eye On FDA Blog has analyzed 235 Warning Letters (WLs) and Notice of Violation (NOVs) letters issued by FDA's Office of Pharmaceutical Drug Promotion (OPDP) since 2005....
Survey: Should PhRMA Issue Mobile Health App Guiding Principles?
In February, 2012, in a blog post provocatively titled "An App for That, But For How Much Longer?", PhRMA's Kate Connors agreed with a Washington Times op-ed piece that suggested the...
Rodale’s Study Cites My Estimate Regarding DTC Ad Spending; I’m Flattered, But…
My friend Richard Meyer over at World of DTC Marketing Blog posted some key findings and charts from the 2012 Rodale DTC Study (see "A new era for DTC marketing").
There's a...
FDA’s “Mobile Medical Apps” Scope of Oversight Pyramid: Confusion Abounds
"Consider the 'Mobile medical apps Proposed Scope for Oversight' issued by CDRH ," said DrugWonk Peter Pitts (here). "It’s a pyramid divided into three parts":
Pitts describes these parts of the pyramid:
The...
